"Cancer Vaccine Startup Secures $54 Million Funding, Appoints Spark Veteran as CEO"
Corner Therapeutics, a new startup focusing on developing vaccines for cancers, influenza, and potentially HIV, has launched with $54 million in funding led by Ziff Capital Partners. The company is being led by Steven Altschuler, co-founder of Spark Therapeutics, who joined Ziff Capital in 2018. The startup aims to leverage its expertise in vaccine development to address critical medical needs in the field of oncology and infectious diseases.